Like a dating ritual where the perused finally signals to the pursuer it’s time for the payoff, Allergan, Inc. (NYSE:AGN) is formally sending signals to Bill Ackman and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) that time for action is upon us.
Allergan ready to select the one
After nearly an eight month courtship, an Allergan spokesperson today signaled the biotech firm is ready to select “the one,” a long term partner to merge with.
“The Board remains focused on a single commitment, enhancing value for all of Allergan, Inc. (NYSE:AGN)’s stockholders,” an Allergan spokesperson said in a statement sent to ValueWalk. In other words, we can get it on, but there has to be...


